|
HY-112498-10mg
|
MedChemexpress LLC
|
Cy3 NHS ester [CAS 1393363-07-9]
|
|
|
|
|
HY-112498-25mg
|
MedChemexpress LLC
|
Cy3 NHS ester [CAS 1393363-07-9]
|
|
|
|
|
HY-112498-5mg
|
MedChemexpress LLC
|
Cy3 NHS ester [CAS 1393363-07-9]
|
|
|
|
|
HY-112498-50mg
|
MedChemexpress LLC
|
Cy3 NHS ester [CAS 1393363-07-9]
|
|
|
|
|
HY-118870-10mg
|
MedChemexpress LLC
|
gamma-Globulins from human blood [CAS 9007-83-4]
|
|
COVID-19-anti-virus
|
|
|
HY-118870-100mg
|
MedChemexpress LLC
|
gamma-Globulins from human blood [CAS 9007-83-4]
|
|
COVID-19-anti-virus
|
|
|
HY-118870-25mg
|
MedChemexpress LLC
|
gamma-Globulins from human blood [CAS 9007-83-4]
|
|
COVID-19-anti-virus
|
|
|
HY-118870-5mg
|
MedChemexpress LLC
|
gamma-Globulins from human blood [CAS 9007-83-4]
|
|
COVID-19-anti-virus
|
|
|
HY-118870-50mg
|
MedChemexpress LLC
|
gamma-Globulins from human blood [CAS 9007-83-4]
|
|
COVID-19-anti-virus
|
|
|
HY-122907-10mg
|
MedChemexpress LLC
|
JNJ4796 [CAS 2241664-16-2]
|
|
COVID-19-anti-virus
|
|
|
HY-122907-25mg
|
MedChemexpress LLC
|
JNJ4796 [CAS 2241664-16-2]
|
|
COVID-19-anti-virus
|
|
|
HY-122907-5mg
|
MedChemexpress LLC
|
JNJ4796 [CAS 2241664-16-2]
|
|
COVID-19-anti-virus
|
|
|
HY-13218-10mg
|
MedChemexpress LLC
|
Acitazanolast [CAS 114607-46-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13218-100mg
|
MedChemexpress LLC
|
Acitazanolast [CAS 114607-46-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13218-25mg
|
MedChemexpress LLC
|
Acitazanolast [CAS 114607-46-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13218-5mg
|
MedChemexpress LLC
|
Acitazanolast [CAS 114607-46-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13218-50mg
|
MedChemexpress LLC
|
Acitazanolast [CAS 114607-46-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-134669-10mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
|
HY-134669-100mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
|
HY-134669-25mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
|
HY-134669-5mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
|
HY-134669-50mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
|
HY-138200-10mg
|
MedChemexpress LLC
|
Cy5 maleimide [CAS 1437796-65-0]
|
|
|
|
|
HY-138200-25mg
|
MedChemexpress LLC
|
Cy5 maleimide [CAS 1437796-65-0]
|
|
|
|
|
HY-138200-5mg
|
MedChemexpress LLC
|
Cy5 maleimide [CAS 1437796-65-0]
|
|
|
|
